Cholera News and Research

Latest Cholera News and Research

UCF microbiologist uncovers the evolutionary origins of antimicrobial resistance in bacteria

Bacteria naturally adapt to various environmental stimuli and as they mutate, these changes can make them resistant to drugs that would kill or slow their growth.

5 May 2023

Advancing the development of vaccines through recombinant technology

In this interview, News-Medical talks to Dr. Amy Sheng, the head of CRO at Sino Biological, about current developments in the field of vaccine development through recombinant techniques.

From Sino Biological Inc. 4 May 2023

Using artificial intelligence to improve the predictability of epidemics

Before the first cases of COVID-19 became known, an algorithm based on artificial intelligence developed by a company in Canada had already detected a new virus which was spreading across the Chinese city of Wuhan.

20 Apr 2023

Nonsurgical system for controlled delivery of antibiotics to treat aggressive periodontitis in adolescents

Aggressive periodontitis is a severe type of gum infection that causes the destruction of ligament and bone and can lead to tooth loss in otherwise healthy individuals.

20 Apr 2023

£18.5 million in UK funding to provide safe, reliable water supply and sanitation services in Asia and Africa

Speaking at the first UN High-Level Conference on Water in 40 years, UK Climate and Environment Minister, Lord Goldsmith announced new support to improve the quality of water supply, and sanitation and hygiene services in South Asia and sub-Saharan Africa.

22 Mar 2023

New solutions to boost Africa’s vaccine production

The COVID-19 pandemic has highlighted the importance of vaccines in controlling infectious disease in sub-Saharan Africa and renewed interest in vaccine research and development across the continent.

28 Feb 2023

Researchers devise a novel potential IBD treatment strategy that eliminates pathogenic T cells and encourages the proliferation of regulatory T cells

Researchers investigated the CAMCI strategy as an immunotherapeutic option for inflammatory bowel disease.

31 Jan 2023

State-of-the-art Biocontainment Unit opened at MedStar Washington Hospital Center

MedStar Washington Hospital Center has opened a state-of-the-art Biocontainment Unit that will be used primarily for observation and flexed for respiratory isolation and further flexed to care for patients with highly infectious diseases.

19 Jan 2023

Malawi’s cholera outbreak exacerbated by inadequate funding for water and sanitation

Malawi's worsening cholera crisis is the result of long-term neglect of the country's water supplies and water testing urgently needed, specialists say.

19 Jan 2023

Researchers review bacteriophage treatment

Researchers presented an overview of bacteriophage treatment, including mechanisms, types, design and applications of bacteriophage therapy.

10 Jan 2023

Study demonstrates safety and efficacy of a three-dose whole-parasite vaccine against malaria

A three-dose regimen of a whole-parasite vaccine against malaria – called Plasmodium falciparum sporozoite (PfSPZ) vaccine – demonstrated safety and efficacy when tested in adults living in Burkina Faso, West Africa, which has endemic malaria.

4 Jan 2023

Exposure to blue-green algae toxin shown to wreak havoc on gut bacteria and cause liver damage

Exposure to a specific type of blue-green algae toxin known as cylindrospermopsin has shown to wreak havoc on gut bacteria and an increased probability of irritable bowel syndrome, inflammatory bowel disease, celiac disease, type 1 diabetes, obesity and inflammation of the liver – a precursor to liver cancer – according to a study led by the University of California, Irvine.

20 Dec 2022

Can the Global Task Force on Cholera Control attain its 2030 targets?

Researchers assessed whether the 2030 goals of the Global Task Force for cholera control are attainable.

13 Dec 2022

Scientists identify molecules in mucus that can block cholera infection

MIT researchers have identified molecules found in mucus that can block cholera infection by interfering with the genes that cause the microbe to switch into a harmful state.

13 Dec 2022

IVI and Lemonex sign MOU to join forces on vaccine development

The International Vaccine Institute announced on November 10 it signed a memorandum of understanding (MOU) with Lemonex, a company specializing in RNA gene therapy development, and agreed to seek cooperation in research and development.

10 Nov 2022

Did COVID-19 mitigation measures in the United Kingdom impact the transmission of other infectious diseases?

Researchers explored the impact of the coronavirus disease 2019 (COVID-19) pandemic-associated non-pharmaceutical prevention measures on the transmission of 22 infectious diseases in England.

25 Oct 2022

Research sheds light on specific protein interaction that could provide new treatment strategy to combat Cholera

Bacterial infectious diseases are still a huge contributor to global disease burden and with antibiotic resistance on the rise worldwide there is an urgent need for novel treatment strategies against bacteria.

14 Oct 2022

The impact of the infant gut microbiome on vaccine efficacy

A new study reports the effect of the infant gut microbiome on vaccine efficacy.

13 Sep 2022

Researchers develop new technique to keep drinking water safe at refugee settlements

Waterborne illness is one of the leading causes of infectious disease outbreaks in refugee and internally displaced persons (IDP) settlements, but a team led by York University has developed a new technique to keep drinking water safe using machine learning, and it could be a game changer.

6 Sep 2022

Discovery of bacteria-killing toxin could pave the way for new generation of antibiotics

Researchers at McMaster University have discovered a previously unknown bacteria-killing toxin that could pave the way for a new generation of antibiotics.

6 Sep 2022

Cholera News and Research

Latest Cholera News and Research

UCF microbiologist uncovers the evolutionary origins of antimicrobial resistance in bacteria

Advancing the development of vaccines through recombinant technology

Using artificial intelligence to improve the predictability of epidemics

Nonsurgical system for controlled delivery of antibiotics to treat aggressive periodontitis in adolescents

£18.5 million in UK funding to provide safe, reliable water supply and sanitation services in Asia and Africa

New solutions to boost Africa’s vaccine production

Researchers devise a novel potential IBD treatment strategy that eliminates pathogenic T cells and encourages the proliferation of regulatory T cells

State-of-the-art Biocontainment Unit opened at MedStar Washington Hospital Center

Malawi’s cholera outbreak exacerbated by inadequate funding for water and sanitation

Researchers review bacteriophage treatment

Study demonstrates safety and efficacy of a three-dose whole-parasite vaccine against malaria

Exposure to blue-green algae toxin shown to wreak havoc on gut bacteria and cause liver damage

Can the Global Task Force on Cholera Control attain its 2030 targets?

Scientists identify molecules in mucus that can block cholera infection

IVI and Lemonex sign MOU to join forces on vaccine development

Did COVID-19 mitigation measures in the United Kingdom impact the transmission of other infectious diseases?

Research sheds light on specific protein interaction that could provide new treatment strategy to combat Cholera

The impact of the infant gut microbiome on vaccine efficacy

Researchers develop new technique to keep drinking water safe at refugee settlements

Discovery of bacteria-killing toxin could pave the way for new generation of antibiotics

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Cholera News and Research

Latest Cholera News and Research

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Newsletters you may be interested in